S. Szmit, W. W. Jędrzejczak, and G. Opolski, “Consensus statement on indications for the use of non-pegylated liposomal doxorubicin in patients with lymphomas and concomitant cardiovascular diseases”, OncoReview, vol. 3, no. 3(11), pp. 213-215, Oct. 2013.